QIAGEN Shares Outstanding 2010-2022 | QGEN
QIAGEN shares outstanding history from 2010 to 2022. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- QIAGEN shares outstanding for the quarter ending September 30, 2022 were 0.230B, a 0.88% decline year-over-year.
- QIAGEN 2021 shares outstanding were 0.232B, a 0.93% decline from 2020.
- QIAGEN 2020 shares outstanding were 0.234B, a 3.28% increase from 2019.
- QIAGEN 2019 shares outstanding were 0.227B, a 2.86% decline from 2018.
QIAGEN Annual Shares Outstanding
(Millions of Shares) |
| 2021 |
232 |
| 2020 |
234 |
| 2019 |
227 |
| 2018 |
233 |
| 2017 |
233 |
| 2016 |
239 |
| 2015 |
239 |
| 2014 |
243 |
| 2013 |
233 |
| 2012 |
232 |
| 2011 |
230 |
| 2010 |
232 |
| 2009 |
206 |
QIAGEN Quarterly Shares Outstanding
(Millions of Shares) |
| 2022-09-30 |
230 |
| 2022-06-30 |
230 |
| 2022-03-31 |
232 |
| 2021-12-31 |
232 |
| 2021-09-30 |
232 |
| 2021-06-30 |
232 |
| 2021-03-31 |
231 |
| 2020-12-31 |
234 |
| 2020-09-30 |
236 |
| 2020-06-30 |
234 |
| 2020-03-31 |
232 |
| 2019-12-31 |
227 |
| 2019-09-30 |
227 |
| 2019-06-30 |
233 |
| 2019-03-31 |
234 |
| 2018-12-31 |
233 |
| 2018-09-30 |
235 |
| 2018-06-30 |
234 |
| 2018-03-31 |
233 |
| 2017-12-31 |
233 |
| 2017-09-30 |
233 |
| 2017-06-30 |
233 |
| 2017-03-31 |
235 |
| 2016-12-31 |
239 |
| 2016-09-30 |
239 |
| 2016-06-30 |
239 |
| 2016-03-31 |
238 |
| 2015-12-31 |
239 |
| 2015-09-30 |
228 |
| 2015-06-30 |
228 |
| 2015-03-31 |
229 |
| 2014-12-31 |
243 |
| 2014-09-30 |
232 |
| 2014-06-30 |
232 |
| 2014-03-31 |
234 |
| 2013-12-31 |
233 |
| 2013-09-30 |
233 |
| 2013-06-30 |
225 |
| 2013-03-31 |
233 |
| 2012-12-31 |
232 |
| 2012-09-30 |
233 |
| 2012-06-30 |
231 |
| 2012-03-31 |
230 |
| 2011-12-31 |
230 |
| 2011-09-30 |
229 |
| 2011-06-30 |
232 |
| 2011-03-31 |
231 |
| 2010-12-31 |
231 |
| 2010-09-30 |
230 |
| 2010-06-30 |
233 |
| 2010-03-31 |
227 |
| 2009-12-31 |
232 |
| 2009-09-30 |
201 |
| 2009-06-30 |
196 |
| 2009-03-31 |
196 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$11.086B |
$2.252B |
|
QIAGEN N.V. is one of the world's leading providers of technologies and products for the separation, purification and handling of nucleic acids DNA/RNA. The company provides innovative technologies and products for pre-analytical sample preparation and molecular diagnostics solutions. It has developed a comprehensive portfolio of proprietary, consumable products, and automated solutions for sample collection. Qiagen has subsidiaries several other countries with good sales potential. Segment Details Consumables: These are typically sample preparation or test kits that contain all the necessary reagents and buffers, and a manual including protocols and relevant background information. Automated Instruments: These automate the use of Sample & Assay Technologies into efficient solutions for a broad range of laboratory needs. Customer Classes: QIAGEN focuses on 4 principal segments or customer classes for sample and assay technologies:? Molecular Diagnostics, Applied Testing, Pharma and Academia.
|
